Smiths has not reported any serious injuries or deaths related to the issues, but the FDA sees a risk of harm.

Smiths Medical also identified three issues associated with the potential for thermal damage in affected infusion pumps. If certain parts of the pump are damaged, heat can melt the plastic housing to ...

The FDA issued three notices identifying warnings sent out by ICU Medical's Smiths Medical unit related to infusion pump problems.

The company has asked users to monitor patients frequently to ensure the appropriate infusion is being delivered.

The Food and Drug Administration issued Class I recalls, the most serious type, for two Smiths Medical infusion pumps due to the potential for serious injury or death.

Report Ocean published the latest research report on the India Infusion Pumps Market. In order to comprehend a market holistically, a variety of factors must be evaluated, including demographics, ...

This advanced, MRI-compatible infusion pump extends Iradimed’s unique position as the world’s only supplier of non-magnetic MRI infusion pump devices, established with our first-generation ...

Aim: The COSTABRAX study evaluated the cost–effectiveness of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) versus polyethylated castor oil-based standard paclitaxel (sb-paclitaxel ...

Nab-paclitaxel does not require premedication for hypersensitivity reactions, has a shorter infusion time (30 min for nab-paclitaxel vs 3 h for CrEL-paclitaxel) and does not require special ...